A Meta-analysis of the Association of ApaI, BsmI, FokI, and TaqI Polymorphisms in the Vitamin D Receptor Gene with the Risk of Polycystic Ovary Syndrome in the Eastern Mediterranean Regional Office Population

Overview

Journal Int J Reprod Biomed

Specialty Reproductive Medicine

Date 2022 Aug 12

PMID 35958959

Authors

Arvin Shahmoradi

Abbas Aghaei

Kimya Ghaderi

Mohammad Jafar Rezaei

Asaad Azarnezhad

Affiliations

Soon will be listed here.

Abstract

Background: The results of case-control studies on the association between vitamin D receptor gene () polymorphisms and polycystic ovary syndrome (PCOS) are inconclusive.

Objective: We aimed to more precisely evaluate the correlation between the ApaI, BsmI, FokI, and TaqI gene polymorphisms and PCOS susceptibility.

Materials And Methods: PubMed, Scopus, Science Citation Index, and Google Scholar databases were searched to retrieve related reports released up to the end of 2020. To evaluate the association strength of the gene polymorphisms with PCOS risk, pooled odds ratios (OR) with a 95% confidence interval were determined.

Results: In total, 1,119 subjects (560 PCOS cases and 559 controls) from 7 studies were included which met the inclusion criteria. A statistically significant association between the TaqI polymorphism and PCOS susceptibility was found in the Eastern Mediterranean Regional Office population (T vs. t: OR = 0.715; TT vs. tt: OR = 0.435, p 0.001; TT vs. Tt+tt: OR = 0.696, p = 0.01; tt vs. TT+Tt: OR = 1.791, p 0.001). It was found that the ApaI variant was a risk factor in the dominant inheritance model (AA vs. Aa+aa: OR = 1.466, p = 0.01) and the FokI polymorphism was a protective factor in the recessive inheritance model (ff vs. FF+Ff: OR = 0.669, p = 0.04). The BsmI polymorphism did not show association with PCOS susceptibility.

Conclusion: Our meta-analysis revealed that the ApaI in the dominant model, FokI in the recessive model, and TaqI polymorphisms in all genetic models are associated with vulnerability to PCOS. However, further studies with a larger sample size are required.

Citing Articles

Vitamin D receptor (VDR) gene polymorphisms and risk for polycystic ovary syndrome and infertility: An updated systematic review and meta-analysis.

Heidarzadehpilehrood R, Hamid H, Pirhoushiaran M Metabol Open. 2025; 25:100343.

PMID: 39866289 PMC: 11764755. DOI: 10.1016/j.metop.2024.100343.

Association of Gene Polymorphisms with Polycystic Ovary Syndrome: A Meta-analysis.

Abinaya G, Iyshwarya B, Veerabathiran R Gynecol Minim Invasive Ther. 2024; 13(4):232-240.

PMID: 39660240 PMC: 11626897. DOI: 10.4103/gmit.gmit_106_23.

Association of VDR gene variant rs2228570-I with gestational diabetes mellitus susceptibility in Arab women.

Alzaim M, Ansari M, Al-Masri A, Khattak M, Alamro A, Alghamdi A Heliyon. 2024; 10(11):e32048.

PMID: 38882352 PMC: 11177144. DOI: 10.1016/j.heliyon.2024.e32048.

Hypermethylation and down-regulation of vitamin D receptor (VDR) as contributing factors for polycystic ovary syndrome (PCOS): a case-control study from Kashmir, North India.

Ashraf A, Singh R, Ganai B, Mir S Arch Gynecol Obstet. 2024; 309(3):1091-1100.

PMID: 38227018 DOI: 10.1007/s00404-023-07326-9.

Do alkaline phosphatases have great potential in the diagnosis, prognosis, and treatment of tumors?.

Jiang T, Zeng Q, He J Transl Cancer Res. 2023; 12(10):2932-2945.

PMID: 37969388 PMC: 10643954. DOI: 10.21037/tcr-23-1190.

References

Bid H, Konwar R, Aggarwal C, Gautam S, Saxena M, Nayak V . Vitamin D receptor (FokI, BsmI and TaqI) gene polymorphisms and type 2 diabetes mellitus: a North Indian study. Indian J Med Sci. 2009; 63(5):187-94. View

Abdollahzadeh R, Sobhani Fard M, Rahmani F, Moloudi K, Kalani B, Azarnezhad A . Predisposing role of vitamin D receptor (VDR) polymorphisms in the development of multiple sclerosis: A case-control study. J Neurol Sci. 2016; 367:148-51. DOI: 10.1016/j.jns.2016.05.053. View

Ollila M, West S, Keinanen-Kiukaanniemi S, Jokelainen J, Auvinen J, Puukka K . Overweight and obese but not normal weight women with PCOS are at increased risk of Type 2 diabetes mellitus-a prospective, population-based cohort study. Hum Reprod. 2016; 32(2):423-431. PMC: 5260860. DOI: 10.1093/humrep/dew329. View

Shi X, Huang A, Xie D, Yu X . Association of vitamin D receptor gene variants with polycystic ovary syndrome: a meta-analysis. BMC Med Genet. 2019; 20(1):32. PMC: 6376757. DOI: 10.1186/s12881-019-0763-5. View

Maitra A, Pingle R, Menon P, Naik V, Gokral J, Meherji P . Dyslipidemia with particular regard to apolipoprotein profile in association with polycystic ovary syndrome: a study among Indian women. Int J Fertil Womens Med. 2001; 46(5):271-7. View

Baker A, McDonnell D, Hughes M, Crisp T, Mangelsdorf D, Haussler M . Cloning and expression of full-length cDNA encoding human vitamin D receptor. Proc Natl Acad Sci U S A. 1988; 85(10):3294-8. PMC: 280195. DOI: 10.1073/pnas.85.10.3294. View

Niu Y, Wang Y, Jiang G, Bai G, Chai H, Li X . Association Between Vitamin D Receptor Gene Polymorphisms and Polycystic Ovary Syndrome Risk: A Meta-Analysis. Front Physiol. 2019; 9:1902. PMC: 6335351. DOI: 10.3389/fphys.2018.01902. View

Repaci A, Gambineri A, Pasquali R . The role of low-grade inflammation in the polycystic ovary syndrome. Mol Cell Endocrinol. 2010; 335(1):30-41. DOI: 10.1016/j.mce.2010.08.002. View

El-Shal A, Shalaby S, Aly N, Rashad N, Abdelaziz A . Genetic variation in the vitamin D receptor gene and vitamin D serum levels in Egyptian women with polycystic ovary syndrome. Mol Biol Rep. 2013; 40(11):6063-73. DOI: 10.1007/s11033-013-2716-y. View

10.

Asemi Z, Foroozanfard F, Hashemi T, Bahmani F, Jamilian M, Esmaillzadeh A . Calcium plus vitamin D supplementation affects glucose metabolism and lipid concentrations in overweight and obese vitamin D deficient women with polycystic ovary syndrome. Clin Nutr. 2014; 34(4):586-92. DOI: 10.1016/j.clnu.2014.09.015. View

11.

Bagheri M, Abdi Rad I, Hosseini Jazani N, Nanbakhsh F . Lack of Association of Vitamin D Receptor FokI (rs10735810) (C/T) and BsmI (rs1544410) (A/G) Genetic Variations with Polycystic Ovary Syndrome Risk: a Case-control Study from Iranian Azeri Turkish Women. Maedica (Bucur). 2013; 7(4):303-8. PMC: 3593280. View

12.

Ramezani N, Ostadsharif M, Nayeri H . Association of variant of vitamin D receptor gene with polycystic ovary syndrome: A case-control study. Int J Reprod Biomed. 2020; 18(10):877-884. PMC: 7569712. DOI: 10.18502/ijrm.v13i10.7772. View

13.

Wehr E, Trummer O, Giuliani A, Gruber H, Pieber T, Obermayer-Pietsch B . Vitamin D-associated polymorphisms are related to insulin resistance and vitamin D deficiency in polycystic ovary syndrome. Eur J Endocrinol. 2011; 164(5):741-9. DOI: 10.1530/EJE-11-0134. View

14.

Mehdizadeh A, Kalantar S, Sheikhha M, Aali B, Ghanei A . Association of gene with polycystic ovarian syndrome in Iranian women. Int J Reprod Biomed. 2017; 15(8):491-496. PMC: 5653910. View

15.

Dasgupta S, Dutta J, Annamaneni S, Kudugunti N, Battini M . Association of vitamin D receptor gene polymorphisms with polycystic ovary syndrome among Indian women. Indian J Med Res. 2015; 142(3):276-85. PMC: 4669862. DOI: 10.4103/0971-5916.166587. View

16.

Shahrokhi S, Ghaffari F, Kazerouni F . Role of vitamin D in female reproduction. Clin Chim Acta. 2016; 455:33-8. DOI: 10.1016/j.cca.2015.12.040. View

17.

Haussler M, Jurutka P, Mizwicki M, Norman A . Vitamin D receptor (VDR)-mediated actions of 1α,25(OH)₂vitamin D₃: genomic and non-genomic mechanisms. Best Pract Res Clin Endocrinol Metab. 2011; 25(4):543-59. DOI: 10.1016/j.beem.2011.05.010. View

18.

Uitterlinden A, Fang Y, van Meurs J, Pols H, van Leeuwen J . Genetics and biology of vitamin D receptor polymorphisms. Gene. 2004; 338(2):143-56. DOI: 10.1016/j.gene.2004.05.014. View

19.

Afzal M . Health research in the World Health Organization Regional Office for the Eastern Mediterranean. East Mediterr Health J. 2009; 14 Suppl:S67-73. View

20.

Abdollahzadeh R, Moradi Pordanjani P, Rahmani F, Mashayekhi F, Azarnezhad A, Mansoori Y . Association of VDR gene polymorphisms with risk of relapsing-remitting multiple sclerosis in an Iranian Kurdish population. Int J Neurosci. 2017; 128(6):505-511. DOI: 10.1080/00207454.2017.1398158. View